ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

AMRX Amneal Pharmaceuticals Holding Co

5,87
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 02:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Amneal Pharmaceuticals Holding Co AMRX NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 5,87 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
5,87
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
16.4.202414:00BWAmneal Launches PEMRYDI RTU®, the First Ready-to-Use Version..
10.4.202414:00BWAmneal to Report First Quarter 2024 Results on May 3, 2024
28.3.202421:05BWAmneal to Ring the Nasdaq Closing Bell on April 2, 2024
25.3.202421:05BWAmneal Receives U.S. FDA Approval for Ciprofloxacin and..
22.3.202413:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22.3.202413:01EDGAR2Form DEF 14A - Other definitive proxy statements
06.3.202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202423:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202412:13EDGAR2Form 8-K - Current report
01.3.202412:00BWAmneal Reports Fourth Quarter and Full Year 2023 Financial..
29.2.202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202414:00BWAmneal Enters into Exclusive European Licensing Agreement..
13.2.202414:00BWAmneal to Participate at Upcoming Investor Conference
08.2.202422:05GLOBEAmneal Announces Complete Response Resubmission for IPX203..
31.1.202422:05BWAmneal to Report Fourth Quarter and Full Year 2023 Results..
10.1.202414:00BWAmneal Launches Complex Generic Fluorometholone Ophthalmic..
04.1.202422:05BWAmneal Launched Record Number of 39 New Retail and..
26.12.202322:10EDGAR2Form 25 - Notification of the removal from listing and..
26.12.202322:05EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
21.12.202314:00BWAmneal to Participate at the 42nd Annual J.P. Morgan..
15.12.202322:15EDGAR2Form 8-K - Current report
15.12.202322:06EDGAR2Form 8-K/A - Current report: [Amend]
15.12.202322:05BWAmneal Announces Move to Nasdaq
07.12.202314:00BWAmneal and BIAL Announce U.S. Licensing Agreement for..
01.12.202322:15EDGAR2Form SC 13D/A - General statement of acquisition of..
01.12.202322:15EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
01.12.202314:00BWAmneal Expands Portfolio with Addition of Icosapent Ethyl..
20.11.202312:07EDGAR2Form 15-12G - Securities registration termination [Section..
09.11.202300:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.11.202300:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.11.202300:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.11.202300:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.11.202300:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.11.202323:15EDGAR2Form S-8 POS - Securities to be offered to employees in..
08.11.202323:13EDGAR2Form POS AM - Post-Effective amendments for registration..
08.11.202323:12EDGAR2Form POS AM - Post-Effective amendments for registration..
08.11.202323:07EDGAR2Form SC 13D/A - General statement of acquisition of..
08.11.202323:05EDGAR2Form SC 13D/A - General statement of acquisition of..
08.11.202323:03EDGAR2Form SC 13D/A - General statement of acquisition of..
08.11.202322:59EDGAR2Form SC 13D/A - General statement of acquisition of..
08.11.202322:55EDGAR2Form SC 13D/A - General statement of acquisition of..
08.11.202313:40EDGAR2Form 8-K12B - Notification that a class of securities of..
07.11.202312:21EDGAR2Form 8-K - Current report
07.11.202312:00BWAmneal Reports Third Quarter 2023 Financial Results
03.11.202313:00BWAmneal to Participate at Upcoming Investor Conferences
23.10.202322:16EDGAR2Form 8-K - Current report
23.10.202322:05BWAmneal Reports Certain Preliminary Third Quarter 2023..
17.10.202312:51EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

Delayed Upgrade Clock